Inventor
MOE SCOTT T
US25 patents
⚠️ This page may combine multiple inventors who share the name “MOE SCOTT T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NPS PHARMA INC
18 patentsUS6211244B1Apr 3, 2001
Calcium receptor-active compounds
NPS PHARMA INC251 citations98
US6031003AFeb 29, 2000
Calcium receptor-active molecules
NPS PHARMA INC151 citations98
US6001884ADec 14, 1999
Calcium receptor-active molecules
NPS PHARMA INC100 citations97
US6660753B2Dec 9, 2003
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
NPS PHARMA INC160 citations96
US6071970AJun 6, 2000
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC66 citations95
US5981599ANov 9, 1999
Inorganic ion receptor active compounds
NPS PHARMA INC70 citations95
US6429207B1Aug 6, 2002
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
NPS PHARMA INC67 citations92
US6342532B1Jan 29, 2002
Inorganic ion receptor active compounds
NPS PHARMA INC22 citations92
US6017965AJan 25, 2000
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC21 citations92
US6710088B2Mar 23, 2004
Inorganic ion receptor-active compounds
NPS PHARMA INC8 citations73
US6306912B1Oct 23, 2001
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC12 citations73
US6051610AApr 18, 2000
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC8 citations73
US6617358B1Sep 9, 2003
Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their uses
NPS PHARMA INC7 citations72
US7053104B2May 30, 2006
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
NPS PHARMA INC9 citations71
US6211245B1Apr 3, 2001
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC2 citations61
US7268166B2Sep 11, 2007
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC0 citations51
US7087765B2Aug 8, 2006
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC0 citations51
US6750244B2Jun 15, 2004
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC1 citations51